COVID-19大流行与头颈癌医疗差异:展望未来
该文为综述,探讨COVID-19大流行如何可能加剧头颈癌(HNC)患者中原有的种族/民族差异,分析差异驱动因素并提出四项缓解策略。
要点
- 大流行可能通过远程医疗、诊断治疗可及性差异加剧HNC生存差异。
- 分诊与手术优先级协议中隐含偏见是差异驱动因素之一。
- 建议收集种族/民族、收入、教育等可及性数据并制定文化适配方案。
核心结论
- COVID-19大流行可能长期加剧头颈癌患者中原有的种族/民族差异。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- 差异驱动因素包括远程医疗、及时诊断和治疗的可及性差异。
- 分诊、优先排序和安排HNC治疗中的隐含偏见是驱动因素。
- 就业、医保和照护依赖的显著变化也是驱动因素。
关键数值与推荐
- 提出四项缓解策略:收集按种族/民族、收入、教育、社区划分的可及性详细数据。
- 提高对HNC差异的认识。
- 让利益相关者参与制定文化适配的解决方案。
- 确保手术优先级协议最小化种族/民族偏见风险。
临床怎么用
- 临床应关注HNC患者在远程医疗、诊断和治疗可及性上的差异。
- 手术优先级协议需审查以避免种族/民族偏见。
- 收集可及性数据以监测和缓解差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic has profoundly disrupted head and neck cancer (HNC) care delivery in ways that will likely persist long term. As we scan the horizon, this crisis has the potential to amplify preexisting racial/ethnic disparities for patients with HNC. Potential drivers of disparate HNC survival resulting from the pandemic include (a) differential access to telemedicine, timely diagnosis, and treatment; (b) implicit bias in initiatives to triage, prioritize, and schedule HNC-directed therapy; and (c) the marked changes in employment, health insurance, and dependent care. We present four strategies to mitigate these disparities: (a) collect detailed data on access to care by race/ethnicity, income, education, and community; (b) raise awareness of HNC disparities; (c) engage stakeholders in developing culturally appropriate solutions; and (d) ensure that surgical prioritization protocols minimize risk of racial/ethnic bias. Collectively, these measures address social determinants of health and the moral imperative to provide equitable, high-quality HNC care.
引用
- Graboyes E, Cramer J, Balakrishnan K, et al. COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon. Head Neck. 2020. PMID: 32562325. doi:10.1002/hed.26345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。